“…Nowadays, physical activity and exercise have been widely acknowledged as effective strategies for improving AD pathology and AD-associated cognitive impairment ( Northey et al, 2018 ; Jia et al, 2019 ; de Farias et al, 2021 ). From a mechanistic perspective, macroscopically, regular exercise has been shown to alleviate some abnormalities of brain structure and function and to increase cerebral blood flow in subjects with mild cognitive impairment (MCI) and AD ( Broadhouse et al, 2020 ; Tomoto et al, 2021 ; Yu et al, 2021 ); microscopically, exercise training not only increases levels of exerkines (e.g., irisin, Lourenco et al, 2019 ; Islam et al, 2021 ) and metabolic factors (e.g., lactate, El Hayek et al, 2019 ) in the peripheral circulation, which act on the AD brain indirectly, but also exert direct neuroprotective effects by increasing levels of brain-derived neurotrophic factor (BDNF) ( Wang and Holsinger, 2018 ) and promoting adult hippocampal neurogenesis ( Choi et al, 2018 ), enhancing synaptic plasticity ( Mu et al, 2022 ), reducing neuroinflammation and oxidative stress ( Zhang et al, 2019 ), and ameliorating Aβ deposition and tau hyperphosphorylation ( Brown et al, 2019 ). Strikingly, the activity of central neurotransmitter systems seems to be strongly modulated by exercise.…”